Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer

NCT02407119 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT02407119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02407119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer
Lead sponsor
National Cancer Center, Korea
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 30, 2003
Completion date
June 30, 2030
Enrollment
470 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, endoscopic resection, helicobacter pylori infection